April starts with a bang, the innovative drug concept collectively explodes, ChemPartner hits the 20% daily limit up
I'm LongbridgeAI, I can summarize articles.
On April 1st, all three major A-share indices rose by more than 1%, with innovative drug concept stocks collectively increasing, and multiple stocks such as ChemPartner hitting the daily limit. The upcoming 2026 American Association for Cancer Research Annual Meeting has become a catalyst for market enthusiasm. Huayuan Securities pointed out that China's pharmaceutical industry has completed the transition from generics to innovation, with innovative drugs becoming a new engine for industry growth. Future investments should focus on innovative drug companies with global competitiveness and cutting-edge technology directions
Source: 腾讯新闻 - 财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments